Work

A couple of words about the shingles vaccine: A novelty in the Polish doctor’s office

Year: 2025

Type: article

Abstract: Herpes zoster is caused by the reactivation of a primary infection of the varicella-zoster virus. It is particularly common among older individuals, with estimates suggesting that one in three people will develop shingles during their lifetime. This disease can lead to numerous complications, the most frequent of which is postherpetic neuralgia, significantly impacting patients’ quality of life. Currently, two shingles vaccines are registered in the European Union. In 2023, the herpes zoster vaccine Shingrix became available in pharmacies across Poland. Polish physicians should promote this immunization among patients, especially those in high-risk groups. This literature review aims to summarize information from existing literature regarding shingles vaccination, focusing on its effectiveness and role in medicine.

Source: Forum Dermatologicum

DOI: 10.5603/fd.103655

Authors: Zuzanna Cudziło, Hubert Sawczuk, Weronika Ewa Nowak, Marta Kaus, Natalia Klepacz, Hanna Adamska, Katarzyna Pilarczyk, Karina Grzesik, Aleksandra Rabęda, Marta Malicka

Institutions: Szpital im Tadeusza Marciniaka, Independent Public Health Care Institution of the Ministry of the Interior and Administration in Krakow, Kraków, Poland

Language: English

Topic: Herpesvirus Infections and Treatments

Subfield: Epidemiology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: hybrid

OpenAlex ID: W4407146851

FWCI:

Cites:

Cited by:

Related to: 10